close
MENU
Investment
3 mins to read

Rua grows full-year loss as it works out of startup mode

The East Coast cannabis business expects to deliver more medicines in 2023.

Rua’s outgoing chief executive Rob Mitchell.

Andrew Bevin Tue, 30 Aug 2022

Rua Bioscience has almost doubled its full-year loss as it works towards becoming a revenue-generating business.

The NZX-listed medical cannabis business posted a loss of $8.6 million for the 12 months ended June 30, down from a $4.4m loss in its 2021 financial year.

The business generated more

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Andrew Bevin Tue, 30 Aug 2022
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Rua grows full-year loss as it works out of startup mode
Investment,
95565
true